Cargando…
Locoregional therapies and their effects on the tumoral microenvironment of pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is expected to become the second leading cause of death from cancer by 2030. Despite intensive research in the field of therapeutics, the 5-year overall survival is approximately 8%, with only 20% of patients eligible for surgery at the time of diagnosis. The...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099187/ https://www.ncbi.nlm.nih.gov/pubmed/35645539 http://dx.doi.org/10.3748/wjg.v28.i13.1288 |